Patents
Literature
7 results about "Maple syrup" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Maple syrup is a syrup usually made from the xylem sap of sugar maple, red maple, or black maple trees, although it can also be made from other maple species. In cold climates, these trees store starch in their trunks and roots before winter; the starch is then converted to sugar that rises in the sap in late winter and early spring. Maple trees are tapped by drilling holes into their trunks and collecting the exuded sap, which is processed by heating to evaporate much of the water, leaving the concentrated syrup. Most trees produce 5 to 15 gallons of sap per season.
Edible Organic Baby Teether and Method of Manufacture Thereof
An edible organic baby teether is disclosed, comprising a frozen therapeutic confectionery formulated from organic nut butter and natural sweeteners, shaped to be safely chewed and consumed by infants for relief of teething discomfort. The invention provides a dual-function teething aid that offers both cooling therapy and nutritional benefit, eliminating the risks associated with synthetic or non-edible teethers. In the preferred embodiment, the composition includes almond, peanut, or cashew butter blended with organic honey, agave nectar, or maple syrup, molded into a popsicle form with an integrated edible or biodegradable handle for infant grasping. When frozen, the product delivers a soothing, gum-numbing effect, and as it softens, it may be safely ingested, providing essential nutrients such as proteins and healthy fats. A method of manufacture is also disclosed, including steps of mixing, molding, freezing, and packaging the organic composition to achieve a soft-freeze texture optimized for infant safety and enjoyment.
Owner:BRAXTON CHRISTIN +1
Palatable compositions including sodium phenylbutyrate and uses thereof
The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
Owner:ACER THERAPEUTICS INC
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex E1-α, E1-β, and E2 subunits for the treatment of maple syrup urine disease
This disclosure relates to mRNA therapy for the treatment of maple syrup urine disease (MSUD). mRNAs for use in the invention, when administered in vivo, encode branched chain α-ketoacid dehydrogenase complex (BCKDC) E1α, E1β, or E2mRNA therapies of the disclosure increase and / or restore deficient levels of E1α, E1β, or E2 expression and / or BCKDC activity in subjects. mRNA therapies of the invention further decrease abnormal accumulation of branched chain amino acids associated with deficient BCKDC activity in subjects.
Owner:MODERNATX INC
Bottle (Maple Syrup)
1. The name of the design product: wine bottle (maple tree cellar). 2. The use of the design product: as a package for wine. 3. The design points of the design product: the shape, pattern and combination of the product of the patent design. 4. The picture or photo that best indicates the design points: perspective view.
Owner:GUIZHOU HUACHIYUAN SAUCE WINE CO LTD
Pharmaceutical composition and B0AT1 inhibitor
To provide a pharmaceutical product that has B0AT1 inhibitory activity. [Solution] The present invention is based on formula (I): [C1] TIFF2026066243000332.tif44170 [In the formula, each symbol is as described in the specification.] The present invention relates to a pharmaceutical composition containing a compound represented by or a salt thereof, and a B0AT1 inhibitor. One embodiment of the present invention is a pharmaceutical suitable for the prevention and / or treatment of amino acid metabolic disorders such as phenylketonuria, urea cycle disorders, hypertyrosinemia (types 1-3), hypermethioninemia, maple syrup urine disease, homocystinuria, nonketotic hyperglycinemia, propionic acidemia, methylmalonic acidemia, and isovaleric acidemia.
Owner:TANABE PHARMA CORP
Systems and methods for non-invasive microwave testing of bottles of liquids, including alcoholic beverages and edible oils like olive oil
A system for non-invasive microwave testing a bottle of liquid may include an emission probe for emitting a microwave signal through a wall of the bottle into the liquid and a detection probe for receiving at least a portion of the microwave signal from the liquid via the wall. The system includes a classifier configured to distinguish olive oil from some other common vegetable oils, to distinguish real from some imitation maple syrups, and to distinguish between several alcoholic beverages.
Owner:TRUSTEES OF DARTMOUTH COLLEGE THE
AAV-mediated gene therapy for maple syrup urine disease (MSUD)
In some aspects the disclosure provides compositions and methods for promoting expression of functional BCKDHA protein, which is the E1-alpha subunit of the branched-chain alpha-keto acid (BCAA) dehydrogenase complex, in a subject. In some aspects the disclosure provides compositions and methods for promoting expression of functional BCKDHB protein, which is the E1-beta subunit of the branched-chain alpha-keto acid (BCAA) dehydrogenase complex, in a subject. In some aspects the disclosure provides compositions and methods for promoting expression of functional BCKDHA and BCKDHB proteins, in a subject. In some embodiments, the disclosure provides methods of treating a subject having Maple Syrup Urine Disease (MSUD).
Owner:UNIV OF MASSACHUSETTS +1